Source:http://linkedlifedata.com/resource/pubmed/id/15651507
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
2005-1-17
|
| pubmed:commentsCorrections | |
| pubmed:language |
dut
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jan
|
| pubmed:issn |
0028-2162
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
1
|
| pubmed:volume |
149
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
54; author reply 54
|
| pubmed:meshHeading |
pubmed-meshheading:15651507-Dermatologic Agents,
pubmed-meshheading:15651507-Humans,
pubmed-meshheading:15651507-Isoxazoles,
pubmed-meshheading:15651507-Photochemotherapy,
pubmed-meshheading:15651507-Psoriasis,
pubmed-meshheading:15651507-Treatment Outcome,
pubmed-meshheading:15651507-Tumor Necrosis Factor-alpha
|
| pubmed:year |
2005
|
| pubmed:articleTitle |
[The practice guideline 'Photo(chemo)therapy and systemic therapy in severe chronic plaque-psoriasis'].
|
| pubmed:publicationType |
Letter,
Comment
|